✦ LIBER ✦

An alternative splinting and rehabilitation protocol for metacarpophalangeal joint arthroplasty in patients with rheumatoid arthritis

✍ Scribed by N. Burr; A.L. Pratt; P.J. Smith

Book ID: 114466399
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 167 KB
Volume: 15
Category: Article
ISSN: 0894-1130
DOI: 10.1053/hanthe.2002.v15.01541

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Doppler sonographic comparative study on

Doppler sonographic comparative study on usefulness of synovial vascularity between knee and metacarpophalangeal joints for evaluation of articular inflammation in patients with rheumatoid arthritis treated by infliximab

✍ Kiori Shio; Fumiko Homma; Yukiko Kanno; Yukio Yamadera; Yoshito Ohguchi; Tomoe N 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 747 KB

Risk of revision for infection in primar

Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: A prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register

✍ Johannes C. Schrama; Birgitte Espehaug; Geir Hallan; Lars B. Engesæter; Ove Furn 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 211 KB 👁 2 views

Foot-related health care use in patients

✍ Marsman, Anneke F. ;Dahmen, Rutger ;Roorda, Leo D. ;van Schaardenburg, Dirkjan ; 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 186 KB

An alternative, autonomic rationale for

An alternative, autonomic rationale for decreased risk of myocardial infarction in patients with rheumatoid arthritis responsive to anti–tumor necrosis factor therapy: Comment on the article by Dixon et al

✍ Andrew J. Holman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

B cell depletion may be more effective t

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt